Intranasal insulin improves cognition and modulates beta-amyloid in early AD.
Djupesland
Per Gisle
PG
D000281:Administration, Intranasal; D000544:Alzheimer Disease / Q000150:complications / Q000188:drug therapy* / Q000523:psychology; D016229:Amyloid beta-Peptides / Q000037:antagonists & inhibitors / Q000378:metabolism* / Q000502:physiology; D003071:Cognition / Q000187:drug effects* / Q000502:physiology; D003072:Cognition Disorders / Q000150:complications / Q000188:drug therapy / Q000523:psychology; D006801:Humans; D007328:Insulin / Q000008:administration & dosage*
D016229:Amyloid beta-Peptides; D007328:Insulin